In mixed hematopoietic chimerism, the donor red cells win

Haematologica

Volumn 96, Issue 1, 2011, Pages 13-15

  Hsieh, Matthew M ^a   Wu, Catherine J ^b   Tisdale, John F ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b Cancer Vaccine Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APOPTOSIS; CELL TYPE; CHIMERA; DONOR; EDITORIAL; ENGRAFTMENT; ERYTHROCYTE; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; GRAFT FAILURE; HEMATOPOIESIS; HEMOGLOBINOPATHY; HOST CELL; LYMPHOCYTE SUBPOPULATION; RISK ASSESSMENT; SICKLE CELL ANEMIA; THALASSEMIA; TREATMENT RESPONSE;

ANEMIA, SICKLE CELL; CHIMERA; ERYTHROCYTES; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE TOLERANCE; THALASSEMIA; TISSUE DONORS;

EID: 78651107396     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.035576     Document Type: Editorial

References (18)

1. Johnson FL, Look AT, Gockerman J, Ruggiero MR, Dalla-Pozza L, Billings FT 3rd. Bone-marrow transplantation in a patient with sickle- cell anemia. N Engl J Med. 1984;311(12):780-3.
2. Thomas ED, Buckner CD, Sanders JE, Papayannopoulou T, Borgna- Pignatti C, De Stefano P, et al. Marrow transplantation for thalassaemia. Lancet. 1982;2(8292):227-9.
3. Andreani M, Nesci S, Lucarelli G, Tonucci P, Rapa S, Angelucci E, et al. Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation. Bone Marrow Transplant. 2000;25(4):401-4.
4. Walters MC, Patience M, Leisenring W, Rogers ZR, Aquino VM, Buchanan GR, et al. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant. 2001;7(12):665-73.
5. Andreani M, Testi M, Gaziev J, Condello R, Bontadini A, Tazzari PL, et al. Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease. Haematologica 2011;96(1):128-33.
6. Andreani M, Testi M, Battarra M, Indigeno P, Guagnano A, Polchi P, et al. Relationship between mixed chimerism and rejection after bone marrow transplantation in thalassaemia. Blood Transfus. 2008;6(3):143-9.
7. Childs R, Clave E, Contentin N, Jayasekera D, Hensel N, Leitman S, et al. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses. Blood. 1999;94(9):3234-41.
8. Armistead PM, Mohseni M, Gerwin R, Walsh EC, Iravani M, Chahardouli B, et al. Erythroid-lineage-specific engraftment in patients with severe hemoglobinopathy following allogeneic hematopoietic stem cell transplantation. Exp Hematol. 2008;36(9):1205-15.
9. Persons DA, Allay ER, Sabatino DE, Kelly P, Bodine DM, Nienhuis AW. Functional requirements for phenotypic correction of murine beta-thalassemia: implications for human gene therapy. Blood. 2001;97(10):3275-82.
10. Hsieh MM, Kang EM, Fitzhugh CD, Link MB, Bolan CD, Kurlander R, et al. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med. 2009;361(24):2309-17.
11. Wu CJ, Krishnamurti L, Kutok JL, Biernacki M, Rogers S, Zhang W, et al. Evidence for ineffective erythropoiesis in severe sickle cell disease. Blood. 2005;106(10):3639-45.
12. Pootrakul P, Sirankapracha P, Hemsorach S, Moungsub W, Kumbunlue R, Piangitjagum A, et al. A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in thai patients with thalassemia. Blood. 2000;96(7):2606-12.
13. Kong Y, Zhou S, Kihm AJ, Katein AM, Yu X, Gell DA, et al. Loss of alpha-hemoglobin-stabilizing protein impairs erythropoiesis and exacerbates beta-thalassemia. J Clin Invest. 2004;114(10):1457-66.
14. Blouin MJ, De Paepe ME, Trudel M. Altered hematopoiesis in murine sickle cell disease. Blood. 1999;94(4):1451-9.
15. Hasegawa S, Rodgers GP, Dwyer N, Noguchi CT, Blanchette-Mackie EJ, Uyesaka N, et al. Sickling of nucleated erythroid precursors from patients with sickle cell anemia. Exp Hematol. 1998;26(4):314-9.
16. Grasso JA, Sullivan AL, Sullivan LW. Ultrastructural studies of the bone marrow in sickle cell anaemia. I. The structure of sickled erythrocytes and reticulocytes and their phagocytic destruction. Br J Haematol. 1975;31(2):135-48.
17. Cavazzana-Calvo M, Payen E, Negre O, Wang G, Hehir K, Fusil F, et al. Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia. Nature. 2010;467(7313):318-22.
18. Lisini D, Zecca M, Giorgiani G, Montagna D, Cristantielli R, Labirio M, et al. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling. Haematologica. 2008;93(12):1859-67.